Zheng_2010_Neurochem.Res_35_2117

Reference

Title : Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease - Zheng_2010_Neurochem.Res_35_2117
Author(s) : Zheng H , Fridkin M , Youdim MB
Ref : Neurochem Res , 35 :2117 , 2010
Abstract : Zheng_2010_Neurochem.Res_35_2117
ESTHER : Zheng_2010_Neurochem.Res_35_2117
PubMedSearch : Zheng_2010_Neurochem.Res_35_2117
PubMedID: 20981484

Related information

Citations formats

Zheng H, Fridkin M, Youdim MB (2010)
Site-activated chelators derived from anti-Parkinson drug rasagiline as a potential safer and more effective approach to the treatment of Alzheimer's disease
Neurochem Res 35 :2117

Zheng H, Fridkin M, Youdim MB (2010)
Neurochem Res 35 :2117